GlassScriptPhysician profile
Donald Graves
NPI 1841579471
$922.41
in general payments reported to CMS, 2019-2025
16 companies · $24.74 in 2025
The $24.74 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $261 · 2021: $151 · 2022: $126 · 2023: $65.22 · 2024: $17.05 · 2025: $24.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $256.11 | 2019-2023 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $237.98 | 2020 | |
| Janssen Pharmaceuticals, INC | $100.46 | 2021 | |
| Orthofix Medical, INC. | $76.52 | 2021-2025 | Physio-Stim |
| Integra Lifesciences Corporation | $52.91 | 2019-2022 | |
| Kerecis Limited | $29.96 | 2022 | |
| Medline Industries LP | $23.40 | 2020 | |
| Tactile Systems Technology INC | $19.74 | 2022 | |
| Depuy Synthes Sales INC. | $18.07 | 2021 | |
| Lightbody Medical Technologies INC | $17.05 | 2024 | |
| Convatec INC. | $16.94 | 2022 | |
| Zimvie INC. | $15.53 | 2023 | |
| Novo Nordisk INC | $15.00 | 2019 | |
| Smith+Nephew, INC. | $14.88 | 2019 | |
| Bsn Medical INC | $14.40 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Graves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.